John Dunn
General Counsel bij CALCIMEDICA, INC.
Profiel
John Michael Dunn is currently a Director at Agility Clinical, Inc., BIOCOM, CONNECT, and The University of Wyoming Foundation.
He is also the General Counsel at CalciMedica, Inc. starting in 2023.
Previously, he held positions as a Director at Acer Therapeutics, Inc., Sharp HealthCare, and Opexa Therapeutics, Inc. He was an Independent Director at Acer Therapeutics, Inc. from 2017 to 2023.
From 2003 to 2012, he served as the Executive Vice President at Biogen, Inc. He was also the Secretary, Senior VP-Legal & Compliance at IDEC Pharmaceuticals Corp.
from 2002 to 2003.
Additionally, he worked as the Secretary & General Counsel at Vital Therapies, Inc. from 2014 to 2019.
He held the position of Executive Vice President at Biogen Idec New Ventures, Inc. from 2002 to 2008.
Prior to that, he was a Partner at Pillsbury Winthrop LLP from 1984 to 2001.
Mr. Dunn obtained his undergraduate and graduate degrees from the University of Wyoming.
Actieve functies van John Dunn
| Bedrijven | Functie | Begin |
|---|---|---|
| CALCIMEDICA, INC. | General Counsel | 20-03-2023 |
Agility Clinical, Inc.
 Agility Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Agility Clinical, Inc. operates as a specialty consulting and clinical research organization. It offers project management services, including project feasibility, study budget and timeline management, study tracking reports, risk assessment, mitigation, and vendor management; clinical operations services, such as investigator selection, regulatory document collection and submission, TMF set up and maintenance, clinical monitoring, and site management; and data management services, which include database design and validation, data cleaning, and EDC. The company was founded by Ellen Morgan and David F. Hale in April 2012 and is headquartered in Carlsbad, CA. | Director/Board Member | - |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Director/Board Member | - |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | - |
The University of Wyoming Foundation
 The University of Wyoming Foundation Investment Trusts/Mutual FundsMiscellaneous The University of Wyoming Foundation operates as a non-profit organization which raises, receives and manages private gifts to maximize support for the University of Wyoming. It offers degrees in agricultural and applied economics, animal science, plant sciences, communications, microbiology, and other educational services. The company was founded in 1962 and is headquartered in Laramie, WY. | Director/Board Member | - |
Eerdere bekende functies van John Dunn
| Bedrijven | Functie | Einde |
|---|---|---|
| ACER THERAPEUTICS INC. | Director/Board Member | 17-11-2023 |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | General Counsel | 12-04-2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2012 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Corporate Officer/Principal | 31-12-2008 |
| ░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Opleiding van John Dunn
| University of Wyoming | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| CALCIMEDICA, INC. | Health Technology |
| Bedrijven in privébezit | 12 |
|---|---|
Agility Clinical, Inc.
Agility Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Agility Clinical, Inc. operates as a specialty consulting and clinical research organization. It offers project management services, including project feasibility, study budget and timeline management, study tracking reports, risk assessment, mitigation, and vendor management; clinical operations services, such as investigator selection, regulatory document collection and submission, TMF set up and maintenance, clinical monitoring, and site management; and data management services, which include database design and validation, data cleaning, and EDC. The company was founded by Ellen Morgan and David F. Hale in April 2012 and is headquartered in Carlsbad, CA. | Commercial Services |
Acer Therapeutics, Inc. /Old/
 Acer Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. develops therapeutics for the treatment of orphan diseases. Its current pipeline consists of two late-stage clinical products: ACER-002 for vascular Ehlers-Danlos Syndrome (vEDS), and ACER-001 for Maple Syrup Urine Disease (MSUD). The company was founded by Chris Schelling and is headquartered in Cambridge, MA. | Health Technology |
| Pillsbury Winthrop LLP | Commercial Services |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Sharp HealthCare
 Sharp HealthCare Hospital/Nursing ManagementHealth Services Sharp HealthCare provides medical and healthcare services. It offers services in the areas of advance care planning, alcohol, drug dependency, bloodless medicine, cancer treatment, diabetes and eating disorders. The company was founded by William Haffey in 1946 and is headquartered in San Diego, CA. | Health Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Commercial Services |
The University of Wyoming Foundation
The University of Wyoming Foundation Investment Trusts/Mutual FundsMiscellaneous The University of Wyoming Foundation operates as a non-profit organization which raises, receives and manages private gifts to maximize support for the University of Wyoming. It offers degrees in agricultural and applied economics, animal science, plant sciences, communications, microbiology, and other educational services. The company was founded in 1962 and is headquartered in Laramie, WY. | Miscellaneous |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
